HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

UG Healthcare: FY25 Financial Performance and Strategic Expansion

UG Healthcare Corporation Limited significantly improved its financial standing in FY25, narrowing its net...
SGX-LISTED COMPANIES

Grand Banks Yachts: FY2025 Financial Results and Outlook

Grand Banks Yachts Limited has reported a period of strong financial performance, marked by...
SGX-LISTED COMPANIES

TAKA Jewellery Holdings: FY2025 Financial Results and Outlook

TAKA Jewellery Holdings Limited delivered improved financial results for the full year ended June...
SGX-LISTED COMPANIES

mm2 Asia: FY2025 Financial Review and Future Strategy

mm2 Asia LTD experienced a demanding financial year, reporting an overall net loss influenced...
SGX-LISTED COMPANIES

Shangri-La Asia Limited: 2025 Interim Results

For the first half of 2025, Shangri-La Asia Limited navigated market headwinds, leading to...
SGX-LISTED COMPANIES

Spindex Industries FY2025 Full Year Financial Statement

Spindex Industries Limited experienced a volatile FY2025, where a slight increase in full-year revenue...
SGX-LISTED COMPANIES

Ellipsiz Ltd: FY2025 Financial Results and Dividend Announcement

Ellipsiz Ltd experienced a notable financial turnaround in FY2025, transitioning from an overall loss...
SGX-LISTED COMPANIES

CFM Holdings FY2025 Loss

CFM Holdings Limited reports a loss after tax for the full year ended 30...
SGX-LISTED COMPANIES

Lion Asiapac: Q4 and FY2025 Loss

Lion Asiapac Limited is set to report a loss for the fourth quarter and...
SGX-LISTED COMPANIES

Worley Limited 2025 Annual Financial Results

Worley has delivered a strong result for the fourth consecutive year, reporting growth in...
SGX-LISTED COMPANIES

Koda FY2025 Financial Results Announcement

Koda Ltd achieved a significant financial turnaround in FY2025, reversing a previous loss to...
SGX-LISTED COMPANIES

Chuan Hup Holdings Full Year 2025 Financial Report

Chuan Hup Holdings Limited experienced a robust FY2025, marked by a significant increase in...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...